iShares U.S. Pharmaceuticals ETF (IHE)
NYSEARCA: IHE · Real-Time Price · USD
100.96
+2.67 (2.72%)
Jul 2, 2026, 4:00 PM EDT - Market closed
IHE Holdings Information
IHE is an equity ETF with a total of 60 individual holdings. The top holdings are Johnson & Johnson stock at 22.79%, Eli Lilly and Company at 22.07%, Merck & Co. at 4.50%, Royalty Pharma at 4.38%, and Viatris at 4.35%.
Total Holdings
60
Top 10 Percentage
76.35%
Asset Class
Equity
ETF Category
Health
Assets
921.54M
PE Ratio
23.44
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | 22.79% |
| 2 | LLY | Eli Lilly and Company | 22.07% |
| 3 | MRK | Merck & Co., Inc. | 4.50% |
| 4 | RPRX | Royalty Pharma plc | 4.38% |
| 5 | VTRS | Viatris Inc. | 4.35% |
| 6 | BMY | Bristol-Myers Squibb Company | 4.32% |
| 7 | PFE | Pfizer Inc. | 3.93% |
| 8 | ZTS | Zoetis Inc. | 3.80% |
| 9 | JAZZ | Jazz Pharmaceuticals plc | 3.42% |
| 10 | ELAN | Elanco Animal Health Incorporated | 2.79% |
| 11 | AXSM | Axsome Therapeutics, Inc. | 2.36% |
| 12 | CORT | Corcept Therapeutics Incorporated | 1.93% |
| 13 | LGND | Ligand Pharmaceuticals Incorporated | 1.43% |
| 14 | DFTX | Definium Therapeutics, Inc. | 1.28% |
| 15 | LQDA | Liquidia Corporation | 1.24% |
| 16 | INDV | Indivior Pharmaceuticals, Inc. | 1.09% |
| 17 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.00% |
| 18 | OGN | Organon & Co. | 0.80% |
| 19 | EWTX | Edgewise Therapeutics, Inc. | 0.67% |
| 20 | AMRX | Amneal Pharmaceuticals, Inc. | 0.66% |
| 21 | SUPN | Supernus Pharmaceuticals, Inc. | 0.62% |
| 22 | ELVN | Enliven Therapeutics, Inc. | 0.61% |
| 23 | MANE | Veradermics, Incorporated | 0.58% |
| 24 | TARS | Tarsus Pharmaceuticals, Inc. | 0.58% |
| 25 | NKTR | Nektar Therapeutics | 0.54% |
As of Jul 2, 2026